AN UPDATE OF COMBINED MODALITY THERAPY FOR PATIENTS WITH MUSCLE INVADING BLADDER CANCER USING SELECTIVE BLADDER PRESERVATION OR CYSTECTOMY
- 1 August 1999
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Urology
- Vol. 162 (2), 445-450
- https://doi.org/10.1016/s0022-5347(05)68582-5
Abstract
No abstract availableThis publication has 41 references indexed in Scilit:
- Bladder Preservation in Invasive Locally Confined Bladder CancerOncology Research and Treatment, 1996
- 1000 Organ conservation in bladder cancerEuropean Journal of Cancer, 1995
- NEOADJUVANT AND ADJUVANT CHEMOTHERAPY IN ADVANCED DISEASE?WHAT ARE THE EFFECTS ON SURVIVAL AND PROGNOSIS?International Journal of Urology, 1995
- THE PLACE OF RADIATION THERAPY AS DEFINITIVE TREATMENT OF BLADDER CANCERInternational Journal of Urology, 1995
- Results of Medical Research Council Phase II Study of Low Dose Cisplatin and Methotrexate in the Primary Treatment of Locally Advanced (T3 and T4) Transitional Cell Carcinoma of the BladderBJU International, 1991
- Radical Radiation Treatment of Invasive and Locally Advanced Bladder Carcinoma in Elderly PatientsBJU International, 1991
- Neo‐adjuvant Chemotherapy for Invasive Bladder Cancer. Experience with the M‐VAC RegimenBJU International, 1989
- Adjuvant Chemotherapy in T3 Carcinoma of the Bladder A Prospective Trial: Preliminary ReportBJU International, 1988
- Reappraisal of the Role of Radical Radiotherapy and Salvage Cystectomy in the Treatment of Invasive (T2/T3) Bladder CancerBJU International, 1988
- Treatment of Invasive Bladder Cancer by Local Resection and High Dose MethotrexateBJU International, 1984